pioneer 6 oral semaglutide cardiovascular outcomes trial results Post hoc analysis of SUSTAIN and 6 trials suggests that people with type 2 diabetes at high risk treated with experience more stable kidney function compared with placebo Oral semaglutide versus subcutaneous liraglutide

The following GLP-1 medications are FDA-approved for use in the United States: Liraglutide (Saxenda, Victoza) For type 2 diabetes and for long-term weight management in adults and some adolescents with obesity or overweight along with at least one weight-related condition

GLP-1R agonizts prevented the onset of ER stress and subsequent apoptosis in human umbilical vein endothelial cells when stimulated by high glucose 19

Modify your lifestyle as needed While diet has the biggest impact on GLP-1 levels, other lifestyle factors can affect natural GLP-1 production as well

The most common side effects of GLP-1 RAs impact the gastrointestinal tract, typically when starting the medications or when the dosage increases

DOI: 10.3390/molecules25122850

Garcia-Bailo B, Toguri C, Eny KM, El-Sohemy A